An analysis of the multiplicity of the effects of antilymphocyte serum. A comparison with the action of other immunosuppressive agents in the cell-mediated immune response and non-specific inflammation.
D000917:Antibody Formation / Q000187:drug effects*; D000961:Antilymphocyte Serum / Q000494:pharmacology; D002454:Cell Differentiation; D003169:Complement Inactivator Proteins; D003520:Cyclophosphamide / Q000494:pharmacology; D006867:Hydrolases; D007106:Immune Sera; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007249:Inflammation / Q000188:drug therapy*; D008214:Lymphocytes / Q000201:enzymology / Q000276:immunology / Q000378:metabolism; D008727:Methotrexate / Q000494:pharmacology; D008854:Microscopy, Electron; D010587:Phagocytosis; D013792:Thalidomide / Q000494:pharmacology
D000961:Antilymphocyte Serum; D003169:Complement Inactivator Proteins; D007106:Immune Sera; D007166:Immunosuppressive Agents; D013792:Thalidomide; D003520:Cyclophosphamide; D006867:Hydrolases; D008727:Methotrexate